Cancer Incidence and Mortality among Black Individuals, New York City, 2016-2020

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 11,389.2 417.7 414.2-421.3 5,426.4 487.3 481.3-493.3 5,962.8 376.6 372.2-381.0 3,377.2 125.4 123.5-127.4 1,518.6 148.8 145.4-152.3 1,858.6 112.9 110.6-115.3
Oral cavity and pharynx 207.0 7.6 7.1-8.1 127.0 11.5 10.6-12.4 80.0 5.0 4.5-5.5 47.8 1.8 1.5-2.0 31.2 2.9 2.5-3.4 16.6 1.0 0.8-1.3
Esophagus 85.0 3.1 2.8-3.4 54.6 5.0 4.4-5.6 30.4 1.9 1.6-2.2 49.6 1.8 1.5-2.0 31.4 2.9 2.5-3.4 18.2 1.1 0.9-1.3
Stomach 267.0 10.1 9.5-10.6 141.6 13.7 12.7-14.8 125.4 7.9 7.3-8.5 112.0 4.3 3.9-4.6 65.2 6.5 5.8-7.2 46.8 2.9 2.5-3.3
Colorectal 973.4 36.3 35.3-37.3 464.8 43.4 41.6-45.3 508.6 31.7 30.5-33.0 345.4 12.9 12.3-13.6 158.8 15.5 14.4-16.7 186.6 11.3 10.6-12.1
Colon excluding rectum 715.2 26.6 25.8-27.5 323.0 30.3 28.8-31.9 392.2 24.3 23.2-25.5 285.2 10.7 10.1-11.3 126.0 12.3 11.4-13.4 159.2 9.6 9.0-10.4
Rectum & rectosigmoid 258.2 9.6 9.1-10.2 141.8 13.1 12.1-14.1 116.4 7.4 6.8-8.0 60.2 2.3 2.0-2.5 32.8 3.2 2.7-3.7 27.4 1.7 1.4-2.0
Liver / intrahepatic bile duct 279.4 9.7 9.2-10.3 188.0 16.2 15.2-17.3 91.4 5.3 4.9-5.9 166.0 5.9 5.5-6.3 108.2 9.8 8.9-10.7 57.8 3.4 3.0-3.8
Pancreas 377.0 13.8 13.2-14.5 166.2 15.3 14.2-16.4 210.8 12.8 12.0-13.6 269.6 9.9 9.4-10.4 119.8 11.1 10.2-12.1 149.8 9.0 8.3-9.7
Larynx 71.0 2.5 2.2-2.8 53.0 4.8 4.2-5.4 18.0 1.1 0.8-1.3 23.2 0.8 0.7-1.0 17.0 1.6 1.3-2.0 6.2 0.3 0.2-0.5
Lung and bronchus 1,071.0 39.0 37.9-40.1 525.4 48.8 46.9-50.7 545.6 32.8 31.5-34.0 556.8 20.4 19.6-21.2 286.2 27.2 25.7-28.7 270.6 16.2 15.3-17.1
Melanoma of the skin 24.4 0.9 0.8-1.1 9.2 0.9 0.6-1.2 15.2 1.0 0.8-1.2 4.2 0.2 0.1-0.2 1.8 0.2 0.1-0.3 2.4 0.1 0.1-0.3
Female breast             1,849.6 119.6 117.2-122.2             343.2 21.3 20.3-22.4
Cervix uteri             145.6 9.9 9.1-10.6             45.6 2.9 2.6-3.4
Corpus uterus and NOS             573.2 34.0 32.8-35.3             176.6 10.4 9.7-11.2
Ovary             153.6 9.8 9.1-10.6             95.8 5.7 5.2-6.3
Prostate       2,152.2 183.6 180.0-187.2             272.4 29.6 28.1-31.3      
Testis       23.6 2.1 1.8-2.6             1.4 0.2 0.1-0.3      
Urinary bladder (incl. in situ) 266.4 10.0 9.4-10.5 178.8 17.7 16.5-19.0 87.6 5.3 4.8-5.9 60.8 2.3 2.1-2.6 37.2 4.0 3.4-4.6 23.6 1.4 1.2-1.7
Kidney and renal pelvis 381.2 13.8 13.2-14.5 229.4 20.4 19.2-21.6 151.8 9.4 8.7-10.1 53.6 2.0 1.7-2.2 34.6 3.3 2.8-3.8 19.0 1.1 0.9-1.4
Brain and other central nervous system 112.0 4.4 4.0-4.8 60.6 5.5 4.9-6.2 51.4 3.5 3.1-4.0 53.8 2.1 1.8-2.3 29.6 2.7 2.3-3.2 24.2 1.6 1.3-1.9
Thyroid 248.4 9.7 9.2-10.3 45.8 4.2 3.7-4.8 202.6 14.0 13.1-14.9 13.0 0.5 0.4-0.6 3.2 0.3 0.2-0.5 9.8 0.6 0.4-0.8
Hodgkin lymphoma 68.2 2.7 2.4-3.0 34.6 3.1 2.6-3.6 33.6 2.5 2.1-2.9 5.4 0.2 0.1-0.3 2.6 0.2 0.1-0.4 2.8 0.2 0.1-0.4
Non-Hodgkin lymphomas 403.4 15.4 14.7-16.1 201.0 18.6 17.4-19.8 202.4 13.2 12.4-14.1 88.2 3.4 3.0-3.7 47.0 4.5 3.9-5.1 41.2 2.6 2.2-3.0
Myeloma 359.0 13.3 12.7-13.9 163.6 15.3 14.2-16.4 195.4 12.0 11.3-12.8 103.0 3.8 3.5-4.2 46.6 4.5 3.9-5.2 56.4 3.4 3.0-3.8
Leukemias 262.8 10.1 9.6-10.7 132.0 12.5 11.5-13.5 130.8 8.6 7.9-9.3 104.6 4.0 3.7-4.4 52.0 5.1 4.5-5.8 52.6 3.3 2.9-3.8

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.